This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Aetiology

Authoring team

The most common cause are

  • polycystic ovarian syndrome (PCOS) – around 72% of women with clinical hyperandrogenism have PCOS (1)
  • idiopathic - androgen levels are not increased, resulting from hypersensitivity of the hair follicle to androgen (2). There may be a raised level of peripherally derived androgens such as 3 alpha-androstanediol glucorinide. The condition usually begins in the early teens and increases with age. A family history may be present.

Other causes:

  • adrenal -
    • non-classic congenital adrenal hyperplasia (less than 5%)
    • congenital adrenal hyperplasia
    • Cushing's syndrome
    • virilizing tumour
  • pituitary -
    • acromegaly
    • hyperprolactinaemia (1)
  • ovarian -
    • virilising tumours
    • gonadal dysgenesis
  • thyroid dysfunction (1)
  • iatrogenic -
    • drugs - androgenic drugs, oral contraceptives, phenytoin
  • menopause – is thought to be due to decreasing oestrogen levels leading to unopposed androgen effects, most present with facial hirsutism (4)
  • Turner's syndrome

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.